1st Patient in Illinois Discharged Home with the SynCardia Total Artificial Heart

64-Year-Old Retired Letter Carrier Had HeartMate II LVAD for   Four Years Prior to Receiving the Total Artificial Heart at Advocate Christ Medical Center.

SynCardia Systems, Inc.,   manufacturer of the world’s first and only FDA, Health Canada and CE (Europe)   approved Total Artificial Heart, announced today that Advocate Christ Medical   Center in Oak Lawn, Illinois, has discharged its first patient to receive the   SynCardia temporary Total Artificial Heart. Leroy Haynes, 64, left the   hospital using the Freedom® portable driver on Sept. 13, to resume life at   home with his wife Pat while he waits for a matching donor heart.

“I can’t thank you enough,”   Haynes told his doctors and nurses during a news conference with his wife by   his side. “We’re just simple people. We’ve worked all of our lives and it   seems saying thank you is not good enough… There’s not a person that didn’t smile,   give me encouragement, tell me I’m going home, and now that day has come.”

Haynes, a letter carrier who   retired from the post office in 2007, had been suffering from cardiomyopathy,   a disease that weakens and enlarges the heart muscle. In 2008, he received a   HeartMate II left ventricular assist device (LVAD). An LVAD is a   continuous-flow, mechanical pump that is implanted adjacent to the heart to   help the left ventricle pump blood. However, this April, Haynes was admitted   to the hospital after his condition began to rapidly deteriorate.

Over several weeks, he   experienced persistent ventricular tachycardia (a fast heart rhythm that   starts in the lower part of the heart), which caused continuous shocks from   his implantable cardioverter defibrillator (ICD). To save his life, on May 8,   doctors removed Haynes’ failing heart and LVAD, and implanted their first   SynCardia Total Artificial Heart to bridge him to a donor heart transplant…   read more

View news coverage of Advocate’s first discharge
Watch videos about Advocate’s first discharge
Read press release from Advocate


Posted in AZBio News and tagged .